Rah, rah, ROS: Metabolic changes caused by loss of adhesion induce cell death

Breast Cancer Research

Volumn 11, Issue 6, 2009, Pages

  Young, Christian D ^a   Anderson, Steven M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

ANCHORAGE INDEPENDENT GROWTH; ANOIKIS; ARTICLE; CELL ADHESION; CELL DEATH; CELL METABOLISM; EPITHELIUM CELL; GLUCOSE METABOLISM; BREAST TUMOR; FEMALE; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL ADHESION; CELL DEATH; CELL LINE, TUMOR; FEMALE; HUMANS; REACTIVE OXYGEN SPECIES;

EID: 77954618932     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2417     Document Type: Article

References (12)

1. Wang J, Yi J. Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther 2008, 7:1875-1884.
2. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat Rev Drug Discov 2009, 8:579-591. 10.1038/nrd2803, 19478820.
3. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, Wahl GM. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell 2002, 9:1031-1044. 10.1016/S1097-2765(02)00520-8, 12049739.
4. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997, 275:1649-1652. 10.1126/science.275.5306.1649, 9054359.
5. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008, 320:661-664. 10.1126/science.1156906, 18388260.
6. Schumacker PT. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 2006, 10:175-176. 10.1016/j.ccr.2006.08.015, 16959608.
7. Gilmore AP. Anoikis. Cell Death Differ 2005, 12(Suppl 2):1473-1477. 10.1038/sj.cdd.4401723, 16247493.
8. Simpson CD, Anyiwe K, Schimmer AD. Anoikis resistance and tumor metastasis. Cancer Lett 2008, 272:177-185. 10.1016/j.canlet.2008.05.029, 18579285.
9. Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, Gao S, Puigserver P, Brugge JS. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 2009, 461:109-113. 10.1038/nature08268, 19693011.
10. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695. 10.1016/j.cell.2006.11.001, 17110329.
11. Greenlee H, Hershman DL, Jacobson JS. Use of antioxidant supplements during breast cancer treatment: a comprehensive review. Breast Cancer Res Treat 2009, 115:437-452. 10.1007/s10549-008-0193-0, 18839308.
12. DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 2007, 104:19345-19350. 2148292, 18032601, 10.1073/pnas.0709747104.